Clinical Decision Support for Diabetic Foot Ulcers

The Growing Problem of Diabetic Foot Ulcers

  • Diabetic Foot Ulcers (DFUs) are a problem that affects 9.1 million to 26.1 million patients worldwide.
  • Undiagnosed, misdiagnosed, or untreated DFUs, both complicate and extend length of care.
Diabetes affects 37.3 million people in the US
Million new diabetics being diagnosed every year
Of diabetics will develop a Diabetic Foot Ulcer in their lifetime

Evaluation and Diagnosis

DFU Evaluation
and Diagnosis

Currently, there are no diagnostic imaging products that utilize AI technology that provide clinicians with an objective and immediate assessment of a DFUs healing potential. Therefore, healthcare professionals rely on subjective assessments based on their experience to determine if wounds, such as diabetic foot ulcers, will respond to treatment.

Predicting DFU’s Healing
is Difficult

Currently, there are no diagnostic tools available for wound healing prediction

Where We Come In

Spectral AI Provides
Clinical Decision Support for Wound Healing

DeepView®  is designed to allow clinicians to make a highly accurate, timely and informed decision regarding the treatment of a patient’s wound. Spectral AI’s DeepView® technology allows quicker time to advance therapy, which in turn reduces overall clinician visits while improving patient satisfaction.

Spectral AI’s DeepView technology provides 86% accuracy in predicting if a DFU will close 50% by week 4.

diabetic foot care management background image

More about Deepview

Learn more about our DeepView® technology

Request a Demo

Looking to learn more about DeepView® technology, or eager to see it in action?